Premature ejaculation treatment market to grow by $1.53b by 2029

Thanks to the high efficacy of off-label drugs and the emerging trend of nanotechnology.

The global premature ejaculation (PE) treatment market is projected to grow by $1.53b by 2029 at a compound annual growth rate of 8.6%, according to Technavio.

The sector’s expansion is driven by the high efficacy of off-label premature ejaculation drugs, as well as the emerging trend of nanotechnology.

Meanwhile, the increased prevalence of PE, which affects individuals during sexual intercourse and leads to difficulties in controlling ejaculation, is also contributing to growth.

However, challenges such as travel restrictions, resource shortages, and delays in clinical trials and regulatory approvals limit the market’s potential.